In this study, we further rigorously demonstrated a novel signalling pathway driven by MCT4 in regulating IBD by modulation of shift balance between NF‐κB‐CBP and CREB‐CBP complex. This evidence concerns the gene NFKB1 and inflammatory bowel disease.